Found 49 matching trials
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy PHASE2 The primary objectives of this study are to evaluate the efficacy, safety, ...
Show More Location
National Cancer Institute, Cairo University
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus PHASE2 This is a Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial Eval...
Show More Location
Multiple Locations
Learn More & Join Trial
Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea N/A The primary objective of this post-marketing surveillance study is to colle...
Show More Location
CHA Bundang Medical Center
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection PHASE3 The primary objectives of this study are to determine the antiviral efficac...
Show More Location
Multiple Locations
Learn More & Join Trial
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection PHASE2 The purpose of this phase 2 study is to determine whether 30 mg or 90 mg of...
Show More Location
Birmingham Gastroenterology Associates, P.C.
Learn More & Join Trial
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant PHASE2 This study will evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combina...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection PHASE2 This study will evaluate the antiviral efficacy, safety, and tolerability o...
Show More Location
Multiple Locations
Learn More & Join Trial
Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection PHASE3 The primary objectives of this study are to evaluate the antiviral efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection PHASE3 This study will evaluate the antiviral efficacy of sofosbuvir (SOF)/ledipas...
Show More Location
Multiple Locations
Learn More & Join Trial